Pfizer Independent Medical Education Grants (Canada): How to Apply

If your organization provides cancer care education, Pfizer’s Independent Medical Education (IME) grants support Canadian programs with measurable impact. A current opportunity focuses on education for ALK‑positive metastatic non‑small cell lung cancer (mNSCLC) and the use of tyrosine kinase inhibitor (TKI) therapy. These grants aim to improve clinical practice. Pfizer does not promote products through this funding.

Pfizer IME Grant for ALK+ mNSCLC TKI Therapy: Program Overview

Program name: Pfizer Independent Medical Education: Fostering Educational Initiatives for ALK+ Metastatic Non‑Small Cell Lung Cancer (mNSCLC) Tyrosine Kinase Inhibitors (TKI) Therapy
Funder: Pfizer International LLC
Status: Open
Jurisdiction: Canada (federal)
Source: Pfizer IME Competitive Grants Program

This grant supports Canadian educational initiatives that address gaps in knowledge and care related to ALK TKI therapy for mNSCLC. Pfizer does not participate in planning, delivering, or controlling funded programs. Your organization must retain full independence over content and execution.

Educational Focus Areas

Funded programs should target one or more of the following priorities:

Long‑term safety of ALK TKI therapies
Management of prolonged treatment duration
Therapy adherence and persistence
Multidisciplinary coordination between academic centres and community care settings

Clinical research, product promotion, or therapeutic efficacy studies are not eligible under this program.

Who Is Eligible to Apply?

Applications must be submitted by an organization, not an individual.

Eligible Canadian organizations include:

Medical, nursing, pharmacy, or allied health schools
Hospitals and healthcare institutions
Professional associations or medical societies
Medical education companies
Other healthcare education or quality improvement organizations

To qualify, your organization must:

Be based in Canada
Employ or formally contract the program lead
Be legally able to receive funds directly from Pfizer International LLC
Hold appropriate accreditation if offering continuing education credits

Funding Amount and Project Timeline

Maximum funding: Up to CAD $100,000 per project
Project duration: Up to 1.5 years

Budgets must be reasonable and clearly justified. All costs should relate directly to educational activities. Pfizer reviews proposals using a competitive process. The review focuses on how well your project matches the educational needs outlined in the grant. For more details, see Pfizer’s official grant guidelines.

How to Apply

The application process requires careful planning and attention to detail.

Step 1: Identify the Educational Gap

Your proposal should explain:

The current practice gap in ALK+ mNSCLC care
The target audience (such as oncologists, nurses, pharmacists)
The importance of this gap in Canadian clinical settings

Step 2: Design an Independent Education Program

Your program may include:

Accredited or non‑accredited continuing education
Workshops, virtual learning, or blended formats
Tools that support multidisciplinary collaboration

All content must be developed independently of Pfizer.

Step 3: Build a Compliant Budget and Timeline

Include:

A line‑item budget tied to program activities
A realistic delivery schedule within 18 months
Clear roles for any partner organizations

Collaborative applications are allowed. One Canadian organization must act as the lead applicant.

Step 4: Submit Through Pfizer’s Grants Portal

Applications are submitted through Pfizer’s Competitive IME Grants system. Deadlines and review cycles are posted on Pfizer’s grants page.

GrantHub can help you compare medical education grants across Canada by funder, province, and focus area.

Common Mistakes to Avoid

Proposing product-specific education
IME funding cannot promote or favour a Pfizer product. Content must be balanced and evidence-based.
Including clinical research activities
Trials, efficacy data collection, or investigator-led research are outside the scope of IME funding.
Weak needs assessment
Applications without a clear educational gap or Canadian context are less likely to succeed.
Accreditation gaps
If you plan to offer CME or CE credits, your organization must already be accredited when the program is delivered.

Frequently Asked Questions

Q: Who can apply for Pfizer Independent Medical Education grants in Canada?
Eligible applicants are Canadian healthcare and education organizations, not individuals. The organization must be able to receive funds directly and employ or contract the program lead.

Q: How much funding is available under this Pfizer IME grant?
Projects may receive up to CAD $100,000 for a maximum duration of 1.5 years, depending on scope and quality.

Q: Does Pfizer help design or deliver the education program?
No. All IME-funded programs must be fully independent. Pfizer does not influence content, speakers, or delivery.

Q: Can the grant be used for accredited continuing medical education?
Yes, accredited education is allowed, as long as your organization holds the required accreditation.

Q: Is Pfizer IME funding taxable in Canada?
Funding is generally treated as grant revenue. You should confirm tax treatment with your accountant based on your organization’s structure.

Next Steps

If your organization delivers oncology education and wants to access funding, consider Pfizer Independent Medical Education grants. GrantHub lists current grant programs across Canada, including industry-funded medical education opportunities. This resource can help you review programs that fit your organization’s needs and timelines.

See also:

What Business Expenses Are Eligible Across Canadian Grants and Loans?
How to Stack Grants and Loans Without Violating Funding Rules
Tax Credits vs Grants for Employee Training in British Columbia

These guides offer support for planning budgets and coordinating funding alongside medical education grants like Pfizer’s IME program.

Pfizer Independent Medical Education Grants (Canada): How to Apply